News

With the robo-taxi launch in the rearview mirror, investors will turn their attention to deliveries, earnings, and the new ...
Musk over the weekend expressed criticism of the budget bill that's working its way through Congress on X, the same social-media platform on which his other comments on the bill (and other matters) ...
INmune Bio Inc. (NASDAQ:INMB) stock fell 60% in pre-market trading Monday after the company reported mixed results from its Phase 2 MINDFuL trial of XPro in early Alzheimer’s disease patients.